Since SCG3 physiologically is expressed in neurons of normal brain tissues (Figure 1F) and its expression in gliomas correlated inversely with malignancy grades (Figure 2), we hypothesized that SCG3 expression would reflect a state of maturity or differentiation in gliomas, thereby would inform better clinical outcomes in glioma patients. Here, SCG3 is linked to glioma.